Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 268 | 2019 |
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 176 | 2019 |
Intracranial hemodynamic relationships in patients with cerebral small vessel disease GW Blair, MJ Thrippleton, Y Shi, I Hamilton, M Stringer, F Chappell, ... Neurology 94 (21), e2258-e2269, 2020 | 107 | 2020 |
Small vessel disease is associated with altered cerebrovascular pulsatility but not resting cerebral blood flow Y Shi, MJ Thrippleton, GW Blair, DA Dickie, I Marshall, I Hamilton, ... Journal of Cerebral Blood Flow & Metabolism 40 (1), 85-99, 2020 | 94 | 2020 |
Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review GW Blair, FN Doubal, MJ Thrippleton, I Marshall, JM Wardlaw Journal of Cerebral Blood Flow & Metabolism 36 (5), 833-841, 2016 | 89 | 2016 |
Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART … RAS Salman, DP Minks, D Mitra, MA Rodrigues, P Bhatnagar, ... The Lancet Neurology 18 (7), 643-652, 2019 | 82 | 2019 |
Advanced neuroimaging of cerebral small vessel disease GW Blair, MV Hernandez, MJ Thrippleton, FN Doubal, JM Wardlaw Current treatment options in cardiovascular medicine 19 (7), 1-17, 2017 | 81 | 2017 |
Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis C McHutchison, GW Blair, JP Appleton, FM Chappell, F Doubal, PM Bath, ... Stroke 51 (8), 2374-2385, 2020 | 79 | 2020 |
Cerebrovascular reactivity measurement in cerebral small vessel disease: Rationale and reproducibility of a protocol for MRI acquisition and image processing MJ Thrippleton, Y Shi, G Blair, I Hamilton, G Waiter, C Schwarzbauer, ... International Journal of Stroke 13 (2), 195-206, 2018 | 64 | 2018 |
Effects of oral anticoagulation for atrial fibrillation after spontaneous intracranial haemorrhage in the UK: a randomised, open-label, assessor-masked, pilot-phase, non … RAS Salman, C Keerie, J Stephen, S Lewis, J Norrie, MS Dennis, ... The Lancet Neurology 20 (10), 842-853, 2021 | 56 | 2021 |
Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The … GW Blair, JP Appleton, K Flaherty, F Doubal, N Sprigg, R Dooley, ... EClinicalMedicine 11, 34-43, 2019 | 40 | 2019 |
Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... JAMA neurology 78 (10), 1179-1186, 2021 | 34 | 2021 |
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease J Wardlaw, PMW Bath, F Doubal, A Heye, N Sprigg, LJ Woodhouse, ... European Stroke Journal 5 (3), 297-308, 2020 | 27 | 2020 |
Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial … GW Blair, JP Appleton, ZK Law, F Doubal, K Flaherty, R Dooley, K Shuler, ... International Journal of Stroke 13 (5), 530-538, 2018 | 27 | 2018 |
Rationale and design of a longitudinal study of cerebral small vessel diseases, clinical and imaging outcomes in patients presenting with mild ischaemic stroke: Mild Stroke Study 3 U Clancy, DJ Garcia, MS Stringer, MJ Thrippleton, MC Valdés-Hernández, ... European stroke journal 6 (1), 81-88, 2021 | 21 | 2021 |
Relationship Between Venules and Perivascular Spaces in Sporadic Small Vessel Diseases ACC Jochems, GW Blair, MS Stringer, MJ Thrippleton, U Clancy, ... Stroke 51 (5), 1503-1506, 2020 | 20 | 2020 |
Zooming in on cerebral small vessel function in small vessel diseases with 7T MRI: Rationale and design of the “ZOOM@ SVDs” study H van den Brink, A Kopczak, T Arts, L Onkenhout, JCW Siero, ... Cerebral Circulation-Cognition and Behavior 2, 100013, 2021 | 19 | 2021 |
Imaging neurovascular, endothelial and structural integrity in preparation to treat small vessel diseases. The INVESTIGATE-SVDs study protocol. Part of the SVDs@ Target project GW Blair, MS Stringer, MJ Thrippleton, FM Chappell, K Shuler, I Hamilton, ... Cerebral Circulation-Cognition and Behavior 2, 100020, 2021 | 16 | 2021 |
Prevalence and Significance of the Vessel-Cluster Sign on Susceptibility-Weighted Imaging in Patients With Severe Small Vessel Disease S Rudilosso, E Chui, MS Stringer, M Thrippleton, F Chappell, GW Blair, ... Neurology 99 (5), e440-e452, 2022 | 14 | 2022 |
MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease MJ Thrippleton, GW Blair, MC Valdes-Hernandez, A Glatz, SIK Semple, ... International journal of molecular sciences 20 (3), 776, 2019 | 12 | 2019 |